Sarah Featherston started my career as a clinical nurse on the pediatric floor at MD Anderson Cancer Center 8 years ago and instantly discovered a passion for oncology, especially stem cell transplant. Three years ago she transitioned from floor nursing to an outpatient role in the Child and Adolescent Center as the Stem Cell Transplant Coordinator.
The new role provided Sarah with a much broader knowledge of the transplant process, and she continues to learn more each day. In the months leading up to CAR-T cell FDA approval in August 2017, Sarah was honored to be involved in planning and implementation of new processes, protocols, and nursing education initiatives for MD Anderson. The CAR-T cell therapy rollout has been very exciting and Sarah is excited to see the positive patient outcomes.
- Putting the Horse before the CAR-T! Educating Nurses on Algorithms to Recognize Cytokine Release Syndrome and CAR-T Related Encephalopathy Syndrome (203)
- The University of Texas MD Anderson Cancer Center
- Houston, Texas